Role of glutamate receptors and voltage-dependent calcium channels in glutamate toxicity in energy-compromised cortical neurons

Japanese Journal of Pharmacology

Volumn 80, Issue 4, 1999, Pages 351-358

  Kimura, Manami ^a   Katayama, Kouichi ^a   Nishizawa, Yukio ^a  

^a EISAI CO LTD   (Japan)

Author keywords

Calcium channel; Cell culture; Energy; Kainate; N methyl D aspartate (NMDA)

Indexed keywords

BUFFER; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; NIFEDIPINE; OMEGA AGATOXIN IVA; OMEGA CONOTOXIN GVIA; VOLTAGE GATED CHANNEL FORMING PROTEIN;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL ENERGY; CONTROLLED STUDY; CULTURE MEDIUM; FETUS; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; RAT; TOXICITY;

EID: 0032850303     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.80.351     Document Type: Article

References (42)

1. Meldrum B: Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin Sci 68, 113-122 (1985)
2. Rothman SM and Olney JW: Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19, 105-111 (1986)
3. Ellren K and Lehmann A: Calcium dependency of N-methyl-D-aspartate toxicity in slices from the immature rat hippocampus. Neuroscience 2, 371-379 (1989)
4. Kimura M, Sawada K, Miyagawa T, Kuwada M, Katayama K and Nishizawa Y: Role of glutamate receptors and voltage-dependent calcium and sodium channels in the extracellular glutamate/aspartate accumulation and subsequent neuronal injury induced by oxygen/glucose deprivation in cultured hippocampal neurons. J Pharmacol Exp Ther 285, 178-185 (1998)
5. MacDermott AB, Mayer ML, Westbrook GL, Smith SJ and Barker JL: NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature 321, 519-522 (1986)
6. Siesjo BK: Mechanisms of ischemic brain damage. Crit Care Med 16, 954-963 (1988)
7. Balentine JD: Spinal cord trauma: in search of the meaning of granular axoplasm and vesicular myelin. J Neuropathol Exp Neurol 47, 77-92 (1988)
8. Meyer FB: Calcium, neuronal hyperexcitability and ischemic injury. Brain Res Rev 14, 227-243 (1989)
9. 2+ channel blocker ω-agatoxin IVA protects against brain injury after focal ischemia in rats. Brain Res 776, 140-145 (1997)
10. Bowersox SS, Singh T and Luther RR: Selective blockade of N-type voltage-sensitive calcium channels protects against brain injury after transient focal cerebral ischemia in rats. Brain Res 747, 343-347 (1997)
11. 2+-channel blocker prevents CA1 injury 24 hr following severe forebrain ischemia and reduces infarction following focal ischemia. J Cereb Blood Flow Metab 14, 903-910 (1994)
12. Takizawa S, Matsushima K, Fujita H, Nanri K, Ogawa S and Shinohara Y: A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia. J Cereb Blood Flow Metab 15, 611-618 (1995)
13. Yenari MA, Palmer JT, Sun GH, Crespigny A, Moseley ME and Steinberg GK: Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI. Brain Res 739, 36-45 (1996)
14. Small DL, Monette R, Buchan AM and Morley P: Identification of calcium channels involved in neuronal injury in rat hippocampal slices subjected to oxygen and glucose deprivation. Brain Res 753, 209-218 (1997)
15. Toner CC and Stamford JA: Involvement of N- and P/Q-but not L-or T-type voltage-gated calcium channels in ischemia-induced striatal dopamine release in vitro. Brain Res 748, 85-92 (1997)
16. Bentué-Ferrer D, Decombe R, Saïag B, Allain H and Van den Driessche J: L-type voltage-dependent calcium channels do not modulate aminergic neurotransmitter release induced by transient global cerebral ischemia: an in vivo microdialysis study in rat. Exp Brain Res 93, 288-292 (1993)
17. 2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc Natl Acad Sci USA 90, 9518-9522 (1993)
18. Kimura M, Yamanishi Y, Hanada T, Kagaya T, Kuwada M, Watanabe T, Katayama K and Nishizawa Y: Involvement of P-type calcium channels in high potassium-elicited release of neurotransmitters from rat brain slices. Neuroscience 66, 609-615 (1995)
19. Lustig HS, Ahern KB and Greenberg DA: ω-Agatoxin IVA and excitotoxicity in cortical neuronal cultures. Neurosci Lett 213, 142-144 (1996)
20. Valentino K, Newcomb R, Gadbois T, Singh T, Bowersox S, Bitner S, Justice A, Yamashiro D, Hoffman BB, Ciaranello R, Miljanich G and Ramachandran J: A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc Natl Acad Sci USA 90, 7894-7897 (1993)
21. Longo R, Sagratella S and Scotti de Carolis A: Effects of calcium antagonists on hypoxic and NMDA injury in rat hippocampal slices. Life Sci 55-6, 455-462 (1994)
22. Teramoto T, Niidome T, Kimura M, Ohgoh M, Nishizawa Y, Katayama K, Mayumi T and Sawada K: A novel type of calcium channel sensitive to ω-agatoxin-TK in cultured rat cerebral cortical neurons. Brain Res 756, 225-230 (1997)
23. 2+/calmodulin-dependent protein kinase II in cultures of hippocampal pyramidal neurons and astrocytes. J Neurosci 8, 1039-1051 (1988)
24. Koh JY and Choi DW: Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 20, 83-90 (1987)
25. Wong EHF, Kemp JA, Priestly T, Knight AR, Woodruff GN and Iversen LL: The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 83, 7104-7108 (1986)
26. Birch PJ, Grossman CJ and Hayes AG: 6,7-Dinitroquinoxaline-2,3-dione antagonizes responses to NMDA in the rat spinal cord via an action at the strychinine-insensitive glycine receptor. Eur J Pharmacol 156, 177-180 (1988)
27. Parsons CG, Gruner R and Rozental J: Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo-(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiazepine (GYKI 52466). Neuropharmacolgy 33, 589-604 (1994)
28. 2+ channels: differences between chicken sympathetic and parasympathetic neurons suggest different regulatory mechanisms. Proc Natl Acad Sci USA 91, 2858-2862 (1994)
29. Reynolds IJ, Wagner JA, Snyder SH, Thayer SA, Olivera BM and Miller RJ: Brain voltage-sensitive calcium channel subtypes differentiated by ω-conotoxin fraction GVIA. Proc Natl Acad Sci USA 83, 8804-8807 (1986)
30. Teramoto T, Kuwada M, Niidome T, Sawada K, Nishizawa Y and Katayama K: A novel peptide from funnel web spider venom, ω-Aga-TK, selectively blocks P-type calcium channels. Biochem Biophys Res Commun 196, 134-140 (1993)
31. Novelli A, Reilly JA, Lysko PG and Henneberry RC: Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 451, 205-212 (1988)
32. Schulz JB, Matthews RT, Henshaw DR and Beal MF: Neuro-protective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases. Neuroscience 71, 1043-1048 (1996)
33. Ferkany JW, Zaczek R and Coyle JT: Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors. Nature 298, 757-759 (1982)
34. Fukunaga K, Muller D and Miyamoto E: CaM kinase II in long-term potentiation. Neurochem Int 28, 343-358 (1996)
35. Kristian T and Siesjo BK: Calcium in ischemic cell death. Stroke 29, 705-718 (1998)
36. Lu YM, Lu BF, Zhao FQ, Yan YL and Ho XP: Accumulation of glutamate is regulated by calcium and protein kinase C in rat hippocampal slices exposed to ischemic states. Hippocampus 3, 221-227 (1993)
37. Koh JY and Choi DW: Selective blockade of non-NMDA receptors do not block rapidly triggered glutamate-induced neuronal death. Brain Res 548, 318-321 (1991)
38. Rothman SM, Thurston JH and Hauhart RE: Delayed neuro-toxicity of excitatory amino acids in vitro. Neuroscience 22, 471-480 (1987)
39. Choi DW: Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Pharmacol Sci 11, 465-469 (1988)
40. Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634 (1988)
41. Bateman MC, Yamada KA and Goldberg MP: AMPA receptor desensitization in hypoxic neuronal injury in vitro. Neurology 43, A339 (1993)
42. Koh JY, Goldberg MP, Hartley DM and Choi DW: Non-NMDA receptor-mediated neurotoxicity in cortical culture. J Neurosci 10, 693-705 (1990)